Concepedia

William G. Wierda

WG

Statistics

Publications

40

Citations

4.7K

H-Index

30

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Utah

City Of Hope National Medical Center

Memorial Sloan Kettering Cancer Center

The Ohio State University

William G. Wierda is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer immunology.

Publications per year

2003–2025

40

Publications

40

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

Michael J. Keating, Susan O’Brien, Maher Albitar et al. · Journal of Clinical Oncology · 2005 · 951 citations · Full text

, , +14

Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies

Romain Guièze, Vivian M. Liu, Daniel Rosebrock et al. · Cancer Cell · 2019 · 360 citations · Full text

, , +16

Non-Hodgkin’s Lymphomas

Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani et al. · Journal of the National Comprehensive Cancer Network · 2010 · 329 citations · Full text

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia

Laura Z. Rassenti, Sonia Jain, Michael J. Keating et al. · Blood · 2008 · 321 citations · Full text

, , +12

Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies

Stefan Faderl, Deborah A. Thomas, Susan O’Brien et al. · Blood · 2003 · 254 citations · Full text

, , +10

1–5 of 40